<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Biotechnology Patent Law Blog &#124; Patents4Life by Warren Woessner &#187; Claim Construction</title>
	<atom:link href="http://www.patents4life.com/category/claim-construction/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.patents4life.com</link>
	<description></description>
	<lastBuildDate>Tue, 31 Jan 2012 14:44:13 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.4</generator>
	<atom:link rel='hub' href='http://www.patents4life.com/?pushpress=hub'/>
		<item>
		<title>ABBOTT LABS. v. SANDOZ, INC. – ONE RULE FITS ALL?</title>
		<link>http://www.patents4life.com/2009/06/abbott-labs-v-sandoz-inc-%e2%80%93-one-rule-fits-all/</link>
		<comments>http://www.patents4life.com/2009/06/abbott-labs-v-sandoz-inc-%e2%80%93-one-rule-fits-all/#comments</comments>
		<pubDate>Fri, 05 Jun 2009 16:24:00 +0000</pubDate>
		<dc:creator>Warren Woessner</dc:creator>
				<category><![CDATA[Claim Construction]]></category>
		<category><![CDATA[Abbott Labs v. Sandoz]]></category>
		<category><![CDATA[Federal Circuit]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[patent attorney]]></category>
		<category><![CDATA[Scripps v. Genetech]]></category>
		<category><![CDATA[USPTO]]></category>
		<category><![CDATA[Warren Woessner]]></category>

		<guid isPermaLink="false">http://www.patents4life.com/2009/06/abbott-labs-v-sandoz-inc-%e2%80%93-one-rule-fits-all/</guid>
		<description><![CDATA[Or “what’s sauce for the goose is sauce for the gander”? Posts and pens have been busy reporting that the Federal Circuit, en banc, overruled Scripps v. Genentech, and ended the debate over whether a product-by-process claims should be construed to be limited by its process steps for the purposes of determining infringement. Judge Newman [...]]]></description>
		<wfw:commentRss>http://www.patents4life.com/2009/06/abbott-labs-v-sandoz-inc-%e2%80%93-one-rule-fits-all/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

